APA (7th ed.) Citation

Negre, O., Bartholomä, C. C., Deichmann, A., Fronza, R., Schmidt, M., & Kalle, C. v. (2015). Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease. Current gene therapy, 15(1), . https://doi.org/ 10.2174/1566523214666141127095336

Chicago Style (17th ed.) Citation

Negre, Olivier, Cynthia C. Bartholomä, Annette Deichmann, Raffaele Fronza, Manfred Schmidt, and Christof von Kalle. "Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-thalassemia and Sickle Cell Disease." Current Gene Therapy 15, no. 1 (2015). https://doi.org/ 10.2174/1566523214666141127095336.

MLA (9th ed.) Citation

Negre, Olivier, et al. "Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-thalassemia and Sickle Cell Disease." Current Gene Therapy, vol. 15, no. 1, 2015, https://doi.org/ 10.2174/1566523214666141127095336.